The Australian Competition and Consumer Commission has conditionally approved Kimberly-Clark Corporation’s proposed acquisition of consumer health company Kenvue Inc. To secure clearance, Kimberly-Clark must sell off Kenvue’s Carefree and Stayfree period care brands in Australia to an independent buyer vetted and approved by the antitrust regulator.
The divestiture mandate addresses significant competitive overlap between the two global consumer goods companies. In Australia, Kimberly-Clark distributes feminine hygiene products under the U by Kotex brand, directly competing with Kenvue’s Carefree and Stayfree offerings across major supermarkets, pharmacies, discount outlets, and online platforms. Alongside competitor Essity—which supplies the Libra and TOM Organic lines—Kimberly-Clark and Kenvue represent two of the country’s three primary period care suppliers. Regulator analysis concluded that allowing a combined entity to retain all three brand portfolios would condense the market to just two major players, substantially lessening competition.
To proactively mitigate antitrust risks prior to formal review, Kimberly-Clark submitted a court-enforceable undertaking agreeing to sell off Kenvue’s period care operations in Australia and New Zealand. ACCC Commissioner Dr Philip Williams noted that requiring a full brand divestment safeguards market dynamics, maintaining a third independent competitor to prevent price distortions and preserve consumer choice.
The approval marks the fourth conditional merger clearance granted under Australia’s updated merger control regime. The reformed regulatory framework mandates pre-acquisition notifications and strict standstill periods, providing the competition watchdog broader oversight to address potential market concentration while ensuring commercial transactions proceed without unnecessary administrative delays.
